Skip to main content
. 2020 Mar 4;3(3):e200396. doi: 10.1001/jamanetworkopen.2020.0396

Table 3. Characteristics of Patients in Propensity Score–Adjusted Cohort by CLABSI Status.

Characteristic No (%) RR (95% CI) P Value
Total (N = 11 796) With CLABSI (n = 158) Without CLABSI (n = 11 638)
Concurrent CVCsa 3932 (33.3) 74 (46.8) 3858 (33.2) 1.83 (1.34-2.50)
Women 5777 (49.0) 68 (43.0) 5709 (49.1) 0.92 (0.67-1.26)
Age, median (IQR), y 59 (47-68) 60 (47-67) 59 (47-68) NA .77
CCI score, median (IQR) 5.0 (3.0-8.0) 4.0 (2.0-7.0) 5.0 (3.0-8.0) NA .25
Receiving chemotherapy 241 (2.0) 9 (5.7) 232 (2.0) 2.96 (1.53-5.72)
Receiving TPN 1404 (11.9) 31 (19.6) 1373 (11.8) 1.81 (1.23-2.67)
Receiving hemodialysis 5118 (43.4) 64 (40.5) 5054 (43.4) 0.89 (0.65-1.22)
CVC type
Port 2247 (19.0) 46 (29.1) 2201 (18.9) 1.75 (1.24-2.45)
PICC 3643 (30.9) 40 (25.3) 3603 (31.0) 0.76 (0.53-1.08)
Otherb 4167 (35.3) 79 (50.0) 4088 (35.1) 1.83 (1.34-2.50)
CLD, median (IQR)
NHSNc 7.0 (4.0-13.0) 17.0 (9.3-23.8) 7.0 (4.0-13.0) NA <.001
Totald 8.0 (4.0-16.0) 21.0 (11.3-33.0) 8.0 (4.0-16.0) NA <.001
NHSN CLD with >1 CVC, median (IQR), % 0 (0-40.0) 0 (0-74.1) 0 (0-40.0) NA .001

Abbreviations: CCI, Charlson Comorbidity Index; CVC, central venous catheter; CLABSI, central line–associated bloodstream infection; CLD, central line–day; IQR, interquartile range; NA, not applicable; NHSN, National Healthcare Safety Network; PICC, peripherally inserted central catheter; port, port-a-cath; RR, risk ratio; TPN, total parenteral nutrition.

a

Concurrence was defined as any 2 CVCs present for 2 or more of the same days.

b

Includes CVC types not listed in the other categories (eg, pulmonary artery catheter, introducer, tunneled CVC, multilumen catheter).

c

Calculated as 1 day for each day any CVC are present (eg, a patient can contribute a maximum of 1 NHSN CLD per day, regardless of the number of CVCs present).

d

Calculated as each day for each CVC (eg, a patient with 2 CVCs for 2 days would have 4 total CLDs).